Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors Meeting Abstract
| Authors: | Park, W.; Zhang, J.; Dayyani, F.; Shan, J.; Liu, R.; Guo, R.; O'Reilly, E. M.; Liu, Z.; Gao, S.; Wu, X.; Starodub, A.; Spira, A. I.; Gabrail, N.; Shah, S.; Chen, Y.; Liu, D.; Cheng, C.; Yu, X. |
| Abstract Title: | Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557400612 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.3002 |
| Notes: | Meeting Abstract: 3002 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
